Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles

Fertility and Sterility

Volumn 100, Issue 5, 2013, Pages 1296-1302

  Lin, Ming Huei ^a,b   Shao Ying Wu, Frank ^c   Kuo Kuang Lee, Robert ^a,d   Li, Sheng Hsiang ^a   Lin, Shyr Yeu ^a   Hwu, Yuh Ming ^a,e  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

Dual trigger; GnRH agonist; GnRH antagonist; normal responders

Indexed keywords

CETRORELIX; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; MUELLERIAN INHIBITING FACTOR; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ARTICLE; BLASTOCYST; COHORT ANALYSIS; CONTROLLED STUDY; EMBRYO; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NIDATION; OOCYTE MATURATION; OVARIAN RESERVE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY;

DUAL TRIGGER; GNRH AGONIST; GNRH ANTAGONIST; NORMAL RESPONDERS;

ACADEMIC MEDICAL CENTERS; ADULT; CHI-SQUARE DISTRIBUTION; CHORIONIC GONADOTROPIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LIVE BIRTH; OOCYTE RETRIEVAL; OVARY; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME; TRIPTORELIN PAMOATE;

EID: 84887080271     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.07.1976     Document Type: Article

References (52)

1. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization J Clin Endocrinol Metab 71 1990 918 922
2. B.C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, and J. Itskovitz-Eldor Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 87 2002 709 715
3. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, K. Diedrich, and G. Griesinger A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of hCG in patients undergoing IVF with GnRH antagonists Hum Reprod 20 2005 2887 2892
4. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grondahl, and L. Westergaard GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220
5. P. Humaidan, L. Bungum, M. Bungum, and C. Yding Andersen Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod Biomed Online 13 2006 173 178
6. P. Humaidan, H. Ejdrup Bredkjaer, L.G. Westergaard, and C. Yding Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil Steril 93 2010 847 854
7. E.G. Papanikolaou, W. Verpoest, H. Fatemi, B. Tarlatzis, P. Devroey, and H. Tournaye A novel method of luteal supplementation with recombinant LH, when a GnRH-agonist is used instead of HCG for ovulation triggering: a randomized prospective proof of concept study Fertil Steril 3 2011 1174 1177
8. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
9. L. Engmann, A. DiLuigi, D. Schmidt, C. Benadiva, D. Maier, and J. Nulsen The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study Fertil Steril 89 2008 554 561
10. S. Kol, N. Lewit, and J. Itskovitz-Eldor Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin releasing hormone analogue as a trigger of ovulation: causes and implications Hum Reprod 11 1996 1143 1144
11. S. Kol Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome Fertil Steril 81 2004 1 5
12. R. Orvieto Can we eliminate severe ovarian hyperstimulation syndrome? Hum Reprod 20 2005 320 322
13. G. Griesinger, S. von Otte, A. Schroer, A.K. Ludwig, K. Diedrich, and S. Al-Hasani Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study Hum Reprod 22 2007 1348 1352
14. L. Engmann, and C. Benadiva Ovarian hyperstimulaton syndrome prevention strategies: luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger Semin Reprod Med 28 2010 506 512
15. M.A. Youssef, F. Van der Veen, H.G. Al-Inany, G. Griesinger, M.H. Mochtar, and I. Aboulfoutouh Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles Cochrane Database Syst Rev 1 2011 CD008046
16. J.C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E.M. Casan, and F. Bonilla-Musoles Cycles triggered with GnRH agonist: exploring low-dose hCG for luteal support Reprod Biomed Online 20 2010 175 181
17. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and S. Thomas Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization Fertil Steril 90 2008 231 233
18. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and C. Hudson Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin Fertil Steril 95 2011 2715 2717
19. D. Griffin, C. Benadiva, N. Kummer, T. Budinetz, J. Nulsen, and L. Engmann Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders Fertil Steril 97 2012 1316 1320
20. M. Schachter, S. Friedler, R. Ron-El, A.L. Zimmerman, D. Strassburger, and O. Bern Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study Fertil Steril 90 2008 1087 1093
21. Y.A. Kim, M.R. Kim, J.H. Lee, J.Y. Kim, K.J. Hwang, H.S. Kim, and E.S. Lee Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis Gynecol Obstet Invest 68 2009 73 81
22. E. Levens, X. Luo, L. Ding, R.S. Williams, and N. Chegini Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGFbeta through Smad and MAPK-mediated signalling Mol Hum Reprod 11 2005 489 494
23. E.M. Casan, F. Raga, F. Bonilla-Musoles, and M.L. Polan Human oviductal gonadotropin-releasing hormone: possible implications in fertilization, early embryonic development, and implantation J Clin Endocrinol Metab 85 2000 1377 1381
24. S.K. Kang, K.C. Choi, C.J. Tai, N. Auersperg, and P.C. Leung Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells Endocrinology 142 2001 580 588
25. J.M. Weiss, B. Krautmacher, S. Polack, K. Diedrich, and O. Ortmann Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells Eur J Endocrinol 149 2003 31 37
26. C.S. Chou, A.G. Beristain, C.D. MacCalman, and P.C. Leung Cellular localization of gonadotropin-releasing hormone (GnRH) I and GnRH II in first-trimester human placenta and decidua J Clin Endocrinol Metab 89 2004 1459 1466
27. L.S. Lin, V.J. Roberts, and S.S. Yen Expression of human gonadotropin releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion J Clin Endocrinol Metab 80 1995 580 585
28. G.A. Jelodar, S. Gholami, and F. Jafarpour Effect of GnRH on guinea pig endometrium at preimplantation stage Indian J Exp Biol 45 2007 242 246
29. J. Liu, C.D. MacCalman, Y.L. Wang, and P.C. Leung Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways Mol Endocrinol 23 2009 1014 1021
30. S. Kol Embryo implantation and GnRH antagonists: GnRH antagonists in ART: lower embryo implantation? Hum Reprod 15 2000 1881 1882
31. J. Liu, B. Cao, Y.X. Li, X.Q. Wu, and Y.L. Wang GnRH I and II up-regulate MMP-26 expression through the JNK pathway in human cytotrophoblasts Reprod Biol Endocrinol 8 2010 5
32. K. Sasaki, and E.R. Norwitz Gonadotropin-releasing hormone/gonadotropin- releasing hormone receptor signaling in the placenta Curr Opin Endocrinol Diabetes Obes 18 2011 401 408
33. B.W. Rackow, H.J. Kliman, and H.S. Taylor GnRH antagonists may affect endometrial receptivity Fertil Steril 89 2008 1234 1239
34. P. Devroey, C. Bourgain, N.S. Macklon, and B.C.J.M. Fauser Reproductive biology and IVF: ovarian stimulation and endometrial receptivity Trends Endocrinol Metabol 15 2004 84 90
35. O. Bukulmez, B.R. Carr, K.M. Doody, and K.J. Doody Serum cetrorelix concentrations do not affect clinical pregnancy outcome in assisted reproduction Fertil Steril 89 2008 74 83
36. K. Zikopoulos, E.M. Kolibianakis, M. Camus, H. Tournaye, E. Van den Abbeel, and H. Joris Duration of GnRH antagonist administration does not effect the outcome of subsequent frozen-thawed cycles Fertil Steril 81 2004 473 475
37. S. Kol, A. Lightman, T. Hilljensjo, P. Devroey, B. Fauser, and B. Tarlazis High doses of GnRH antagonist in IVF cycles do not adversely affect the outcome of subsequent freeze-thaw cycles Hum Reprod 14 1999 2242 2244
38. D. Haouzi, S. Assou, C. Dechanet, T. Anahory, H. Dechaud, J. De Vos, and S. Hamamah Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocol effects Biol Reprod 82 2010 679 686
39. N. Prapas, A. Tavaniotou, Y. Panagiotidis, S. Prapa, E. Kasapi, and M. Goudakou GnRH antagonists and endometrial receptivity in oocyte recipients: a prospective randomized trial Reprod Biomed Online 18 2009 276 281
40. F. Martinez, L. Latre, E. Clua, I. Rodriguez, and B. Coroleu Replacing GnRH agonists with GnRH antagonists in oocyte recipient cycle did not adversely affect the pregnancy rates Eur J Obstet Gynecol Reprod Biol 159 2011 355 358
41. H.G. Al-Inany, M.A. Youssef, M. Aboulghar, F. Broekmans, M. Sterrenburg, J. Smit, and A.M. Abou-Setta Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Cochrane Database Syst Rev 5 2011 CD001750
42. J.B. Oliveira, R. Baruffi, C.G. Petersen, A.L. Mauri, M. Cavagna, and J.G. Franco Jr. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis Reprod Biol Endocrinol 8 2010 107
43. A.J. Zeleznik, A.R. Midgley, and L.E. Reichert Jr. Granulosa cell maturation in the rat: Increased binding of human chorionic gonadotropin following treatment with follicle stimulating hormone in vitro Endocrinology 95 1974 818 825
44. J.S. Richards, J.J. Ireland, M.C. Rao, G.A. Bernath, A.R. Midgley Jr., and L.E. Reichert Jr. Ovarian follicular development in the rat: hormone receptor regulation by estradiol, follicle stimulating hormone and luteinizing hormone Endocrinology 99 1976 1562 1570
45. M.B. Zelinski-Wooten, J.S. Hutchison, D.L. Hess, D.P. Wolf, and R.L. Stouffer Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys Hum Reprod 10 1995 1658 1666
46. C Yding Andersen, L. Leonardsen, A. Ulloa-Aguirre, J. Barrios-De-Tomasi, L. Moore, and A.G. Byskov FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms Mol Hum Reprod 5 1999 726 731
47. S. Stickland, and W.H. Beers Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins J Biol Chem 251 1976 5694 5702
48. J.J. Eppig FSH stimulates hyaluronic acid synthesis by oocyte-cumulus cell complexes from mouse preovulatory follicles Nature 281 1979 483 484
49. D.A. Imoedemhe, A.B. Sigue, E.L. Pacpaco, and A.B. Olazo Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization Fertil Steril 55 1991 328 332
50. K. Oktay, I. Turkcuoglu, and K.A. Rodriguez-Wallberg GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation Reprod Biomed Online 20 2010 783 788
51. J.D. Lamb, S. Shen, C. McCulloch, L. Jalalian, M.I. Cedars, and M.P. Rosen Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trial Fertil Steril 95 2011 1655 1660
52. B. Bankowski, N. Bracero, J. King, J. Garcia, E. Wallach, and N. Vlahos Triggering ovulation with leuprolide acetate is associated with lower pregnancy rate Hum Reprod 19 Suppl. 1 2004 i103